Bone Grafts And Substitutes Industry Variables, Trends & Scope Till, 2020 - 2027: Radiant Insights, Inc

The global bone grafts & substitutes market size is expected to reach USD 3.54 billion by 2026, according to a new report by Grand View Research, Inc. The market is expected to register a healthy CAGR of 4.1% during the forecast period. The availability of advanced products in varied shapes and sizes providing high osteoconductive and osteoinductive properties is supplementing market growth. In minimally invasive procedures, large incisions and damage to muscles surrounding repair area can be significantly avoided. These techniques also reduce the duration of hospital stay and support rapid wound healing with lesser pain and surgical wounds. Thus, rising adoption of bone graft and substitutes in minimally invasive surgical procedures is further anticipated to boost market growth in near future.

Download Free PDF Sample - https://www.radiantinsights.com/research/bone-grafts-and-substitutes-market/request-sample

Minimally invasive total joint replacement and spine surgeries are some of the newly adopted procedures. Moreover, increasing adoption of synthetic bone grafts due to lesser chance of disease transmission is propelling the growth. Key companies operational in the bone grafts and substitutes market space are DePuy Synthes; Medtronic PLC; NuVasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.

Further key findings from the report suggest:

• Increasing number of orthopedic surgeries and rising demand for minimally invasive surgeries are primary factors driving the growth

• By product type, allografts accounted for the largest revenue share as of 2018 in bone grafts & substitutes market, mainly due to properties such as immediate structural support and osteoconductivity. Moreover, allografts do not require another surgery to harvest the bone, which results in reduced surgery time and wound healing, thus, attributing toward segment growth

• Spinal segment held the largest share of the application segment in 2018 owing to the increasing geriatric population and growing number of spinal disorders.

• The dental segment is expected to exhibit the fastest growth over the forecast period owing to the increasing number of dental implant surgeries and technological advancements in dental grafts.

• The U.S. held dominant revenue share of North American market in 2018, owing to rising traumatic injuries, adoption of bone grafts, and number of orthopedic & minimally invasive surgical procedures

• Key players in the market include DePuy Synthes; Medtronic PLC; Nuvasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.

Browse Full Report with TOC - https://www.radiantinsights.com/research/bone-grafts-and-substitutes-market

Table of Contents

Chapter 1 Research Methodology & Scope

1.1 Market Segmentation & Scope

1.1.1 Estimates and Forecast Timeline

1.2 Research Methodology

1.3 Information Procurement

1.3.1 Purchased database:

1.3.2 GVR’s Internal Database

1.3.3 Secondary sources

1.3.4 Primary Research:

1.3.5 Details of Primary Research

1.3.5.1 Data for primary interviews in North America

1.3.5.2 Data for primary interviews in Europe

1.3.5.3 Data for primary interviews in Asia Pacific

1.3.5.4 Data for primary interviews in Middle East and Africa

1.4 Information or Data Analysis

1.4.1 Data Analysis Models

1.5 Market Formulation & Validation

1.6 Model Details

1.6.1 Commodity Flow Analysis (Model 1)

1.6.1.1 Approach 1: Commodity Flow Approach

1.7 List of Secondary Sources

1.8 List of Primary Sources

1.9 Abbreviations

1.10 Report Objectives

Chapter 2 Executive Summary

2.1 Market Outlook

2.1.1 Bone Grafts & Substitutes market Outlook, 2014 - 2026 (USD Million)

2.2 Bone Grafts & Substitutes Market Summary, 2018

Chapter 3 Bone Grafts & Substitutes Market Variables, Trends & Scope

3.1 Technology Timeline Overview

3.1.1 Technology Timeline Bone Grafts & Substitutes changing technology & adoption

3.2 Regulatory Framework

3.3 FDA Consideration

3.3.1 Bone grafts & substitutes that found to be medically necessary

3.4 Reimbursement framework

3.4.1 CPT Coding

3.4.2 HCPCS Coding

3.5 Bone Grafts & Substitutes Market Dynamics

3.5.1 Market driver analysis

3.5.1.1 Rising incidence of bone & joint disorders

3.5.1.2 Advent of biocompatible synthetic graft

3.5.1.3 Rising demand for dental bone grafts

3.5.1.4 Technological advancement

3.5.1.5 Rising geriatric population

3.5.2 Market restraint analysis

3.5.2.1 Stringent regulatory guidelines

3.5.2.2 Risk of disease transmission

3.5.2.3 High cost of bone grafts and substitutes

3.6 Bone Grafts & Substitutes Market Analysis Tools: Porters

3.6.1 Supplier POWER: Low

3.6.2 Buyer POWER: - high

3.6.3 THREAT OF SUBSTITUTES: moderate

3.6.4 THREAT OF NEW ENTRANTS: high

3.6.5 Competitive Rivalry: high

3.7 PESTEL Analysis

3.7.1 Political Landscape

3.7.2 Economic Landscape

3.7.3 Technology Landscape

3.7.4 Social Landscape